SCHEMBL22551167

SCHEMBL22551167

CN1CCC(Oc2ccc(C(=O)Nc3n[nH]c4cc(Nc5ccccc5F)ccc34)cc2)CC1

nearest known ligand 0.61

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KIT P10721 12/20 0.61
FLT3 P36888 10/20 0.61
DYRK1A Q13627 5/20 0.50
GSK3B P49841 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29568259 1.00 KIT (0.61) KITFLT3DYRK1AGSK3B
SCHEMBL29568324 0.92 FLT3 (0.56) KITFLT3
SCHEMBL29568522 0.92 FLT3 (0.56) KITFLT3
SCHEMBL22551159 0.92 FLT3 (0.56) KITFLT3
SCHEMBL22551208 0.92 FLT3 (0.56) KITFLT3
SCHEMBL22551185 0.92 FLT3 (0.56) KITFLT3
SCHEMBL29568400 0.89 FLT3 (0.56) KITFLT3DYRK1AGSK3B
SCHEMBL22551178 0.89 FLT3 (0.56) KITFLT3DYRK1AGSK3B
SCHEMBL22551205 0.85 KIT (0.54) KITFLT3DYRK1AGSK3B
SCHEMBL29569157 0.85 KIT (0.54) KITFLT3DYRK1AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3956315-B1 BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS Rottapharm Biotech Srl (IT) 2025-04-16 EP claimed
EP-3956315-A1 BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS Rottapharm Biotech S.r.l. (IT) 2022-02-23 EP claimed
US-20220041559-A1 BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS ROTTAPHARM BIOTECH S.R.L. (IT) 2022-02-10 US claimed
CN-114008026-A Benzopyrazoles and pyridopyrazoles as protein kinase inhibitors 罗达制药生物技术有限责任公司 2022-02-01 CN claimed
WO-2020212530-A1 BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS ROTTAPHARM BIOTECH S.R.L. (IT) 2020-10-22 WO claimed
EP-3725777-A1 BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS Rottapharm Biotech S.r.l. (IT) 2020-10-21 EP claimed
EP-3956315-B1 BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS Rottapharm Biotech Srl (IT) 2025-04-16 EP disclosed
EP-3956315-A1 BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS Rottapharm Biotech S.r.l. (IT) 2022-02-23 EP disclosed
US-20220041559-A1 BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS ROTTAPHARM BIOTECH S.R.L. (IT) 2022-02-10 US disclosed
US-20220041559-A1 BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS ROTTAPHARM BIOTECH S.R.L. (IT) 2022-02-10 US disclosed
CN-114008026-A Benzopyrazoles and pyridopyrazoles as protein kinase inhibitors 罗达制药生物技术有限责任公司 2022-02-01 CN disclosed
WO-2020212530-A1 BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS ROTTAPHARM BIOTECH S.R.L. (IT) 2020-10-22 WO disclosed
EP-3725777-A1 BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS Rottapharm Biotech S.r.l. (IT) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220041559-A1 BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS PDXK, MAP4K2, PLK2 KIT 1734/4885FLT3 315/4885DYRK1A 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.